November 29, 2021 04:38 ET | Source: Research and Market Research and Market

Dublin, November 29, 2021 (Global News Agency)-The last few days of registration for the "Veterinary Drug Approval Process and FDA Regulatory Oversight Training" seminar, which has been added to ResearchAndMarkets.com products.

This two-day online interactive seminar will allow participants to understand the FDA's veterinary drug approval process in 2021.

The Center for Veterinary Medicine (CVM) of the U.S. Food and Drug Administration is responsible for approving veterinary drug products for household pets, food animals, and other animal species.

This seminar will cover the process of obtaining federal government approval to sell new animal drug products under the jurisdiction of the FDA, and briefly introduce animal products regulated by other federal agencies.

For example, animal vaccines, animal disease diagnostic equipment, and some animal biological products are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.

The group is small, usually between 8 and 10 people, and there are plenty of opportunities to ask questions and discuss issues or challenges encountered by participants.

The main objectives of the seminar will include learning:

Main topics covered: Introduction to the veterinary drug approval process on Day 1

Development of NADA technology

DAY 02 Development of NADA technical part

Overview of Generic Drugs (JINAD)

Minor use minor species (MUMS) designation

Index marketing exclusivity and exclusive marketing rights Animal drug user fees and related exemptions for animal feed, over-the-counter drugs, supplements, medical devices USDA and EPA and non-approved precautions

For more information about this training, please visit https://www.researchandmarkets.com/r/scqbr